Intersection of Biotechnology, Ethics, and the Law

From Idea to Innovation: Real-World Bioethics and IP with Lawrence Lycke

25 min · 20 okt 2025
aflevering From Idea to Innovation: Real-World Bioethics and IP with Lawrence Lycke artwork

Beschrijving

What does it take to turn a life-saving idea into a real product? In this episode, I speak with Lawrence Lycke, Patent Counsel at Kestra Medical Technologies, a company developing next-generation wearable defibrillators. We dive into what happens inside a medical device company as a product moves from concept to clinic—unpacking the practical, legal, and ethical decisions that happen along the way. Lawrence shares what it’s like to navigate real-world intellectual property challenges, the role of patents in innovation, and how companies balance risk, regulation, and responsibility. This is a behind-the-scenes look at the innovation process—what’s exciting, what’s messy, and what matters.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Intersection of Biotechnology, Ethics, and the Law community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

4 afleveringen

aflevering Biotech Startups, Policy, and the Law: A Conversation with Dr. Hans Sauer artwork

Biotech Startups, Policy, and the Law: A Conversation with Dr. Hans Sauer

What’s really at stake when a biotech startup tries to bring something new into the world? In this episode, I speak with Dr. Hans Sauer, Deputy General Counsel and Vice President for Intellectual Property at the Biotechnology Innovation Organization (BIO) and adjunct professor of law at Georgetown Law School. With a legal and scientific career spanning biotech patents, policy, and entrepreneurship, Dr. Sauer shares a big-picture view of what’s working—and what’s still unfolding—in today’s biotech landscape. We talk about the key legal and ethical questions facing biotech startups, how intellectual property influences innovation, and how the biotech sector is pushing law and policy to evolve. It’s a wide-ranging and grounded conversation about the real frameworks that shape biotech outcomes.

21 okt 202554 min